Performance of the Montreal consensus in the diagnosis of gastroesophageal reflux disease in morbidly obese patients

Obesity Surgery

Volumn 18, Issue 6, 2008, Pages 668-674

  Madalosso, Carlos Augusto Scussel ^a,c,d   Fornari, Fernando ^a,b,c   Callegari Jacques, Sidia M ^d   Madalosso, Carlos Antônio ^a,c   Gurski, Richard Ricachenevsky ^d  

^a GASTROBESE   (Brazil)

^b ENDOPASSO   (Brazil)

^c Hospital Sao Vicente de Paulo   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Endoscopy; Esophageal pH monitoring; Gastroesophageal reflux disease; Morbid obesity

Indexed keywords

ADULT; ALGORITHM; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PATIENT CODING; PH MEASUREMENT; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SENSITIVITY AND SPECIFICITY; SYMPTOM;

ADOLESCENT; ADULT; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PRACTICE GUIDELINES AS TOPIC;

EID: 43149120656     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-008-9462-6     Document Type: Article

References (37)

1. Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 2006;29:109-17.
2. Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710-7.
3. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128-38.
4. Sichieri R, Do NS, Coutinho W. The burden of hospitalization due to overweight and obesity in Brazil. Cad Saude Publica. 2007;23:1721-7.
5. Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007;133:34-41.
6. El-Serag HB, Graham DY, Satia JA, et al. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100:1243-50.
7. El-Serag HB, Kvapil P, Hacken-Bitar J, et al. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005;100:2151-6.
8. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199-211.
9. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-31.
10. Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329-30.
11. Deitel M. The obesity epidemic. Obes Surg. 2006;16:377-8.
12. Cawley J, Prinz T, Beane S. Health insurance claims data as a means of assessing reduction in co-morbidities 6 months after bariatric surgery. Obes Surg. 2006;16:852-8.
13. Suter M, Dorta G, Giusti V, et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg. 2004;14:959-66.
14. Pandolfino JE, El-Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639-49.
15. Wu JC, Mui LM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132:883-9.
16. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-20.
17. Fornari F, Gruber AC, Lopes AB, et al. Symptom's questionnaire for gastroesophageal reflux disease. Arq Gastroenterol. 2004;41:263-7.
18. Velanovich V, Vallance SR, Gusz JR, et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996;183:217-24.
19. Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668-85.
20. Jaffin BW, Knoepflmacher P, Greenstein R. High prevalence of asymptomatic esophageal motility disorders among morbidly obese patients. Obes Surg. 1999;9:390-5.
21. Ortiz V, Ponce M, Fernandez A, et al. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients. Obesity (Silver Spring). 2006;14:696-700.
22. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172-80.
23. Wo JM, Castell DO. Exclusion of meal periods from ambulatory 24-hour pH monitoring may improve diagnosis of esophageal acid reflux. Dig Dis Sci. 1994;39:1601-7.
24. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol. 1992;87:1102-11.
25. Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358-61.
26. Abramson JH. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov. 2004;1:6.
27. Bray GA. Obesity: a time bomb to be defused. Lancet. 1998;352:160-1.
28. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763-78.
29. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130:883-90.
30. Linn S, Grunau PD. New patient-oriented summary measure of net total gain in certainty for dichotomous diagnostic tests. Epidemiol Perspect Innov. 2006;3:11.
31. Lee YC, Lin JT, Chiu HM, et al. Intraobserver and interobserver consistency for grading esophagitis with narrow-band imaging. Gastrointest Endosc. 2007;66:230-6.
32. Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974;62:325-32.
33. Aro P, Ronkainen J, Talley NJ, et al. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut. 2005;54:1377-83.
34. Edelstein ZR, Farrow DC, Bronner MP, et al. Central adiposity and risk of Barrett's esophagus. Gastroenterology. 2007;133:403-11.
35. El-Serag HB, Ergun GA, Pandolfino J, et al. Obesity increases oesophageal acid exposure. Gut. 2007;56:749-55.
36. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007;56:756-62.
37. Jansson C, Nordenstedt H, Johansson S, et al. Relation between gastroesophageal reflux symptoms and socioeconomic factors: a population-based study (the HUNT Study). Clin Gastroenterol Hepatol. 2007;5:1029-34.